结直肠癌治疗中的放射性免疫疗法:现在和未来
Jingyi Shi1, Zhuang Sun1, Zhaoya Gao2,3
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Surgery III, Peking University Cancer Hospital & Institute, Beijing, China.
Frontiers in immunology
|May 26, 2023
概括
放射性免疫治疗 (RIT) 结合了结直肠癌 (CRC) 的放射治疗和免疫治疗. 理性RIT疗法对改善CRC患者的治疗结果有希望,但需要进一步的研究来优化治疗策略.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 结肠直肠癌 (CRC) 是一个重大的全球健康挑战,特别是在晚期.
- 目前的手术,化疗和放射治疗等治疗方法都有局限性,复发率和转移率很高.
- 需要创新的治疗策略来改善CRC患者的长期预后.
研究的目的:
- 审查目前放射治疗和免疫治疗在CRC治疗中的应用和机制.
- 系统地评估结直肠癌放射性免疫疗法 (RIT) 的初步临床试验结果.
- 确定RIT疗效的预测因素,并讨论未来的研究方向.
主要方法:
- 对CRC的放射治疗,免疫治疗和RIT现有的文献进行系统审查.
- 对联合放射性免疫治疗的潜在机制的分析.
- 评估初步临床试验数据和确定的疗效预测因素.
主要成果:
- 放射性免疫疗法 (RIT) 已成为结直肠癌的潜在治疗方法.
- 已经确定了RIT疗效的几个关键预测因素,表明了个性化治疗的潜力.
- 预先的RIT临床试验表明,优化的治疗方案可以改善选择的CRC患者的结果.
结论:
- 合理的RIT疗法对某些结直肠癌患者的改善结果有希望.
- 目前的RIT研究设计有限,需要更大的样本大小和优化的组合策略.
- 未来的研究应该专注于根据已识别的影响因素和患者特定预测因素来改进RIT协议.
相关概念视频
Tumor Immunotherapy
584
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
584
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Vaccines
447
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
447
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
207
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
207


